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Background. Plant seeds have gained interest for their health benefits due to their fatty acid content. The objective of this study was
to determine the effects of dietary consumption of milled sesame/pumpkin/flax seed mixture on glycemic control, serum lipids,
phospholipid fatty acid status, and inflammatory factors in patients on hemodialysis.Methods. Thirty patients with well nutrition
status (18male, 12 female) were enrolled in the study. Participants consumed 30 g ofmilled sesame/pumpkin/flax (6 g/6 g/18 g, resp.)
seeds mixture added to their habitual diet. Results. Total n-6 and n-3 polyunsaturated fatty acids and levels of linoleic, dihomo-
gamma-linolenic (DGLA), arachidonic, alpha-linolenic (ALA), eicosapentaenoic, docosapentaenoic, and docosahexaenoic (DHA)
acid were increased after 12 weeks of supplementation. A significant decrease of the serum triglyceride level (𝑃 < 0.001), glucose,
insulin, calculated IR HOMA (𝑃 < 0.05), and inflammatory markers (TNF-alpha, IL-6, and hs-CRP, 𝑃 < 0.001) was observed
after seed mixture treatment. The serum levels of CRP and TNF-alpha negative correlate with ALA, DHA, and DGLA. Conclusion.
Results of this study indicated that dietary milled sesame/pumpkin/flax seed mixture added to a habitual diet lowered triglyceride
and CRP, TNF-alpha, IL-6 levels, affect glycemic control and improved fatty acid profile and pruritus symptoms in hemodialysis
patients.
1. Introduction
Fatty acid composition in serum phospholipids can be used
not only as a biomarker of dietary fat intake quality, but also as
an indicator of disease risk [1, 2]. In observational and inter-
vention studies altered fatty acid composition of phospho-
lipids linked with metabolic and cardiovascular diseases [2–
4].This suggestion implied a continued dietary supply. In our
previous studies we showed that patients on hemodialysis
have higher level of oleic (18 : 1 n-9) and lower levels of eicos-
apentaenoic (EPA) and docosahexaenoic (DHA) acids, with
low levels of total n-6 and n-3 polyunsaturated fatty acid
(PUFA) [5–8]. There are many limitations in the published
studies which deal with changes in fatty acid (FA)metabolism
and PUFA content in chronic renal failure. However, in
general, it can be concluded that patients on hemodialysis
need nutritional care programs with an adequate n-6/n-3
PUFA ratio in their diet [9, 10].
The precursor to long-chain n-3 fatty acid is alpha-
linolenic acid (ALA), which is elongated to EPA and docos-
apentaenoic acid (DPA n-3), possibly more in women than
in men [11, 12]. According to the available literature, further
metabolism of DPA n-3 to DHA is very limited [12, 13].
However, the use of the plant-based n-3 fatty acid to be
alternative to consummation of fish may be important for
maintaining optimal EPA and DHA status in plasma and cell
membranes. It is important to address that serum levels of
ALA significantly increased after ingestion of flax oil and
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milled flaxseed whereas whole flaxseed, did not show the
same effect [14, 15]. Flax, pumpkin, and sesame seeds have
gained interest for their health benefits due to their fatty
acid and lignan contents [16–18]. Flaxseed is also an excellent
source of dietary fiber and contains protein and several
micronutrients. Sesame andflax seeds are considerably differ-
ent in the PUFA content, with a high ALA n-3 level (51–55%)
in flaxseeds and high linoleic acid (LA) n-6 content in sesame
seeds (44%). Since sesame seed is a rich source of n-6 FA
and alsomonounsaturated FA (oleic acid 40%), in addition to
diet, increased serum phospholipids LA levels as biomarker
of intake are observed [19, 20].The seeds of pumpkin are rich
natural source of LA n-6 (40.4–55.6%), oleic acid, and antiox-
idant vitamins, such as carotenoids and tocopherol [21, 22].
The ideal ratio of LA n-6 and ALA n-3 in diet is not known,
but ratio of 1 : 1-2 has been considered beneficial to healthwith
effects on cell membrane fluidity and membrane function
[23]. The balance required in the diet between n-6 and
n-3 fatty acid is important due to their competitive nature and
their different biological roles [24, 25].
Uremic pruritus is one of common symptoms in patients
with end-stage renal disease (ESRD), with approximately
60–90% of patients on hemodialysis suffering from this prob-
lem [26, 27].The pathogenesis of dry, scaly skin, and pruritus
is not known but could be related to the abnormal fatty
acid profile reported in these patients [10, 28]. It is shown that
intervention with fish oil may improve symptoms of pruritus
in hemodialysis patients [28].
In the latest prospective cohort study on inflammation
and death risk, Noori et al. [29] concluded that a higher
dietary n-6/n-3 PUFA ratio appears to be associated with
inflammation and a trend toward higher risk of morality in
hemodialysis patients. Inflammatory states in ESRD are asso-
ciatedwith an elevation ofC-reactive protein (CRP) and some
proinflammatory cytokines such as interleukin-6 (IL-6) and
tumor necrosis factor-alpha (TNF-alpha) [6, 8, 30]. IL-6 is
reported to play a central role in the pathophysiology of
the adverse effects of inflammation in ESRD patients. The
increased activation of inflammatory cytokines such as IL-6
and TNF-alpha may cause muscle breakdown and hypoalbu-
minemia and may be involved in atherogenesis [31, 32].
The purpose of the present study was prospective evalu-
ation of the effects of milled sesame/pumpkin/flax seed mix-
ture dietary treatments on nutrition status, plasma lipids,
phospholipids fatty acid profile, inflammatory markers, and
symptoms of pruritus in patients on hemodialysis.
2. Patients and Methods
We cross-sectionally evaluated 65 patients on maintenance
hemodialysis from the Department of Nephrology, Univer-
sity Hospital Zemun (Belgrade). For this study we included
cohort group of 30 chronic renal failure patients (18 male, 12
female, mean age 55 ± 14 yr; range 42 to 64), who have been
selected based on their well nutrition status. All patients had
been on maintenance hemodialysis three times a week for at
least 6 months and the mean duration of hemodialysis in
included patients was 4.76 ± 3.38 yr. The duration of dialysis
was defined as the number of months from the initiation
of chronic hemodialysis to the time of laboratory data
collection. The patients were clinically stable, with adequate
nutrition status and with no recorded cardiovascular events
(coronary heart disease and cerebrovascular disease). The
mean body mass index (BMI) calculated from dry body
weightwas 22.63±3.44 kg/m2 (range 19.8 to 27.3). Serumalbu-
min concentration was 46.27 ± 7.22 g/L and serum CRP level
was 6.26 ± 4.12mg/mL. Patients were dialyzed with synthetic
membranes and a bicarbonate dialysate with 1.25, 1.5, or
1.75mmol/L calcium according to the serum calcium phos-
phate equilibrium and with obligatory use of 1.25-dihydroxy
vitamin D3 to control the parathyroid hormone levels. The
duration of hemodialysis was individually tailored (4–6 h
weekly) to control body fluids and blood chemistries with the
aim of achieving Kt/V > 1.2 (1.46 ± 0.13). Patients did not
regularly receive epoetin therapy during that time. Antihy-
pertensives were prescribed when it was necessary to obtain
predialysis blood pressure < 160/90mmHg. Patients with
a history of nephrotic syndrome, diabetes mellitus, alcohol
consummation, systemic illness, or any other disease that
might influence lipid metabolism were excluded. None of
the patients received lipid lowering drugs, L-carnitine, 𝛽-
blockersor, vitamin B12 in the 3 months prior to entering the
study. Patients received no other medications except multi-
vitamins, calcitriol phosphate binders, and/or iron. Calcium
carbonate was used to obtain predialysis serum phosphate
level < 2.0mmol/L. Patients maintained their habitual diets
(35 kcal/kg bw, protein intake 1–1.2 g/kg bw, fats < 35% caloric
intake) with sodium and potassium restriction.They had low
habitual consumption of foods containing soy, fish intake
once in twoweeks, and no dietary supplementation of oil rich
in long-chain fatty acid (fish, sesame, or linseed oil) as deter-
mined by diet assessment made at the time of recruitment.
All patients were sedentary (<1 h/wk of physical activity), free
of alcohol consumption, and nonsmokers. All study partici-
pants signed and provided an informed consent document.
Study protocol was approved by the ethical review boards of
the participating institutions in accordance with the princi-
ples of the Declaration of Helsinki.
2.1. Study Design. This study was a cross-sectional and
follow-up dietary intervention study. Patients were instructed
to mix 30 g per day of milled seed mixture containing 6 g
sesame : 6 g pumpkin : 18 g flax (1 : 1 : 3) (company Beyond,
Nis, Serbia; seed mixture was made in our laboratory) in
200mL of fat-free milk (Imlek, Belgrade) in a single evening
dose before dinner during the follow-up period of 12 weeks.
In the present study, the test milled seed mixture was added
to the habitual diet as they have already consumed at least
200mL of fat-free milk a day at the moment they were
recruited for our study. The participants were also instructed
to continue to consume a usual amount of milk. Although
no modification of the habitual diets for these patients was
planned, they were instructed to keep their usual diets and
level of physical activity relatively constant throughout the
study and to maintain stable body weights. Fatty acid profile
of ground seed mixture (analyzed with gas chromatography)
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was sumof palmitic and stearic fatty acid 18%, oleic acid (OA)
30%, LA 24%, and ALA 28%; polyunsaturated/saturated
(PUFA/SFA) fatty acid ratio was 4 : 1 and n-6/n-3 ratio was
1 : 1. Daily fatty acid intake from milled seed mixture was
palmitic acid 0.9 g, stearic 0.7 g, OA 3.9 g, LA 2.9 g, and ALA
3.0 g. Specific instructions were given not to take any new
supplements or increase the amount of fish in the diet. The
patients continued to consume (sunflower oil) n-6 PUFA
cooking oils as part of their usual diet. The diet control was
done as usual for all study participants by interview during
hemodialysis.
For the purpose of this study, uremic pruritus was
defined as pruritus appearing in close conjunction with the
commencement of dialysis or appearing in conjunction with
significant deterioration in renal function [33]. A question-
naire with issues to evaluate subjective feeling of presence
and frequency of pruritus was given to patients at baseline
and after intervention period.The pruritus questionnaire was
used as the short form from Peck et al. [28] for assessment of
uremic pruritus in part of the pruritus history. The questions
covered the presence of dry skin or itching (yes/no), history
of pruritus symptoms (1–4, from never to continuing daily,
weekly, fortnightly, or monthly), severity (1–5, from mild to
total restlessness), distribution (1–3, single location to gener-
alized), and frequency of symptoms (number of episodes per
24 h).
2.2. Biochemical Determination. Blood samples were taken
in the middle of week, after 12–14 h of overnight fasting and
immediately prior to dialysis in the beginning of study and
after 12 weeks. Serum samples were prepared by 4∘C cen-
trifugation of venous blood. Plasma triglyceride, glucose, and
total cholesterol concentrationsweremeasured by using stan-
dard enzyme color tests (EliTech Diagnostic. Sées, France);
HDL cholesterol was determined by the enzyme procedure
(EliTech Diagnostic. Sées, France) in supernatant after pre-
cipitation by the phosphotungstic acid and LDL cholesterol
was estimated by using Friedewald formula. Total phospho-
lipidswere determined by themethodof Zilversmit andDavis
[34]. Insulin level wasmeasured using the radioimmunoassay
method (INEP Zemun, Belgrade, Serbia). Fasting insulin
and glucose concentrations were used to calculate insulin
resistance from the IR-HOMAmodel (insulin× glucose/22.5)
[35].
Serum albumin concentration was determined by using
bromcresol green reagent (EliTech Diagnostic. Sées, France).
Serum ironwasmeasured by a photometric color test for clin-
ical chemistry analyzers (Olympus System Reagent; Olympus
Diagnostica). IL-6 and TNF-alpha concentrations were mea-
sured in duplicate by Immunotech IL-6 immunoassays and
Immunotech TNF-alpha immunoassays (Beckman Coulter,
Fullerton, CA, USA), and hs-CRP was measured by the
Olympus (LATEX) assay on the Olympus AU 400 analyzer
(Olympus, PA, USA) by methods that have already been
reported [7].
2.3. Fatty Acid Determination. Serum lipids were extracted
according to method of Sperry and Brand [36] which uses
chloroform-methanol mixture (2 : 1, v/v) with 10mg/100mL
2.6-di-tert-buthyl-4-methylphenol (BHT) added as an
antioxidant. The phospholipids fraction was isolated from
the lipid extract using one-dimensional thin-layer chro-
matography (TLC) in a neutral lipid solvent system hexane-
diethyl ether-acetic acid (87 : 12 : 1, v/v/v) using Silica Gel GF
plates (C. Merck, Darmstadt, Germany).
Methyl esters of phospholipids FA were prepared by
methods that have already been reported [37]. Fatty acid
methyl esters derivatives were analyzed by gas chromatog-
raphy using Varian GC (model 3400, Varian Associates)
equipped with SP-2330 (30m × 0.53mm i.d., film thickness
0.5 𝜇m; Supelco Inc., Bellefonte, PA) fused silica capillary
column.Analysiswas performed in duplicate for each sample.
Individual FA methyl esters were identified by compar-
ing peak retention times with authentic standards (Sigma
Aldrich, Germany) and/or the PUFA-2 standard mixtures
(Supelco Inc., Bellefonte, PA). The results were expressed as
the relative percentage of total identified FA.
2.4. Statistical Analysis. All the results are expressed as the
mean ± SD. Before being statistically analyzed, all data
were examined for normality by using the Shapiro-Wilks
test. Differences in the absolute changes in fasting plasma
triglycerides, total cholesterol, HDL cholesterol, LDL choles-
terol, albumin, creatinine, hemoglobin, hs-CRP, TNF-alpha,
IL-6, glucose, insulin, iron, calculated IR HOMA, and FA
profile of serum phospholipids over the 12-week period of
milled seed mixture supplementation were determined using
independent-sample 𝑡-tests or Mann-Whitney 𝑈 test for
variables with skewed distribution. The Pearson correlation
coefficients were computed for examination of the relation
between inflammatory factors and fatty acid composition of
serum phospholipids.The differences were considered signif-
icant at 𝑃 ≤ 0.05.
3. Results
3.1. Subject Characteristics. Thebaseline characteristics of the
study participants are presented in Table 1. All participants
completed the study and there were no withdrawals. There
were no significant differences in the anthropometrical char-
acteristics of hemodialysis patients before and after 12 weeks
of milled seed mixture dietary treatments. Most patients (20
participants) had suffered from pruritus for periods ranging
from 6 months to 1 year. In most patients (60%), pruritus
symptoms were aggravated during the night sleeping period
compared to rate of pruritus symptoms during the daytime.
Seed mixture added to diet improves the symptoms of pru-
ritus in all patients. The scores for severity, distribution, and
frequency of pruritus symptoms on the questionnaire showed
a great improvement. Systolic and diastolic blood pressure
were significantly decreased after 12 of weeks of treatment
(𝑃 < 0.01). We also found significant decrease of creatinine
level (𝑃 < 0.05) at the end of the study.This seed mixture was
well tolerated with no significant side effect in hemodialysis
patients.
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Table 1: The baseline characteristics of study participants and responsiveness to milled seed mixture after twelve weeks.
Variable Before treatment After treatment
Age 55 ± 14
Gender (M/F) 30 (18/12)
Duration of HD (years) 4.76 ± 3.38
BMI (kg/m2) 22.63 ± 3.44 22.81 ± 3.62
SBP (mmHg) 155 ± 14 144 ± 13∗∗
DBP (mmHg) 92 ± 9 86 ± 10∗∗
WBC 109/L 6.40 ± 1.46 5.74 ± 1.46
Hematocrit L/L 0.27 ± 0.04 0.26 ± 0.06
Serum creatinine (𝜇mol/L) 785 ± 158 722 ± 156∗
Serum urea (𝜇mol/L) 20.56 ± 2.30 19.41 ± 2.34
Serum iron (𝜇mol/L) 13.67 ± 4.77 14.49 ± 4.34∗
Serum albumin (g/L) 46.27 ± 7.22 43.74 ± 4.05
Serum glucose (mmol/L) 4.76 ± 1.18 4.28 ± 0.82∗
Serum insulin (pg/mL) 23.98 ± 9.42 20.28 ± 6.36∗
IR HOMA 5.09 ± 2.82 3.83 ± 1.35∗
TNF (mU/L) 1.86 ± 0.90 0.72 ± 0.59∗∗∗
IL-6 (pg/mL) 2.63 ± 1.45 0.55 ± 0.34∗∗∗
hs-CRP (mg/L) 6.26 ± 4.12 3.06 ± 1.34∗∗∗
The values are means ± SD. ∗𝑃 ≤ 0.05, ∗∗𝑃 ≤ 0.01, and ∗∗∗𝑃 ≤ 0.001 significantly different from baseline.
3.2. Serum Lipids. Effect of milled seed mixture dietary
treatments on mean serum lipid values for all participating
patients and percentage change are shown in Table 2. After
12 weeks of consuming milled sesame/pumpkin/flax seed
mixture in the hemodialysis patients, total and LDL choles-
terol concentrations had decreased by 7% and 5% (𝑃 < 0.05,
𝑃 > 0.05), respectively (Table 2). The Tg/HDL (𝑃 < 0.01)
ratio significantly decreased but TC/HDL and LDL/HDL
cholesterol ratios decreases remained non statistic. Serum
HDL cholesterol did not differ from baseline values through-
out either feeding period. During 12 weeks of seed mixture
consumption, serum plasma triglyceride levels decreased by
30% (𝑃 < 0.001) compared with baseline values (week 0)
(Table 2).
3.3. Fatty Acid Profile of Serum Phospholipids. The fatty acid
profiles of serumphospholipids before and after treatment are
shown in Table 3. Saturated 16 : 0 (𝑃 < 0.01), 18 : 0 (𝑃 < 0.01),
and total SFA (𝑃 < 0.001) were significantly decreased and
oleic acid (𝑃 < 0.05) and total MUFA increased (𝑃 < 0.01)
in serum phospholipids after treatments. Percentages of LA
(𝑃 < 0.01), dihomo-𝛾-linoleic (DGLA; 20 : 3n-6) (𝑃 < 0.01),
AA (𝑃 < 0.05), ALA (𝑃 < 0.05), EPA (𝑃 < 0.05), DPA n-3
(𝑃 < 0.05), andDHA (𝑃 < 0.01) in serumphospholipidswere
significantly higher after 12 weeks of intervention. Consistent
with the previous were the increases in n-6 PUFA n-3 PUFA,
total PUFA, and PUFA/SFA ratios as well (𝑃 < 0.001 for all
mentioned parameters) (Table 3).
3.4. Glucose Tolerance and Inflammatory Markers. A signif-
icant decrease of the glucose, insulin, calculated IR HOMA
(𝑃 < 0.05 for all mentioned variables), and inflammatory
markers (TNF-alpha, IL-6, hs-CRP, 𝑃 < 0.001) was observed
after dietary intervention (Table 1). The serum levels of CRP
negative correlate with ALA, DHA, DGLA, and AA in serum
phospholipids (Table 4). There was very strong negative
correlation between serum TNF-𝛼 and ALA, DHA, LA, and
DGLA. The serum levels IL-6 negative correlate with ALA,
DPAn-3, DGLA, and AA in serum phospholipids (Table 4).
4. Discussion
The results clearly demonstrate that dietary treatment with
milled sesame/pumpkin/flax seeds mixture (30 g; rich in
n-6 and n-3 FA) for 12 weeks has the capacity to improve
traditional lipid levels, inflammatory markers, and serum
fatty acid composition as biomarker of status in hemodialysis
patients. We also showed the efficacy of increasing levels of
not only EPA, but also DHA in plasma phospholipids by
providing its precursor ALA (3.0 g) from seed mixture. That
was inconsistent with reports that EPA can limitedly be
converted to DHA [12, 38]. Therefore, it is important to
emphasize that our patients have low intake of fish, once every
two weeks, as poor eating patterns of people in our region
[25]. Human clinical studies show that an increase in dietary
ALA leads to significant increases in ALA, EPA, and DPAn-
3 in the blood [39, 40] and they are carried out using daily
intakes of > 5 g ALA. It is well known that fatty acid composi-
tion of the serum phospholipids clearly reflects the change of
dietary habits [41, 42]. This is proved by analysis of fatty acid
status in our hemodialysis patients after dietary treatment.
Our findings for changes of LA levels in serumphospholipids,
LA being the most represented fatty acid (2.9 g) in our seed
mixture beside ALA (3.0 g), are consistent with Okita et al.
[42] who reported that the LA levels in serum phospholipids
appeared to reflect the dietary LA content.
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Table 2: Baseline serum lipids profile responsiveness to milled seed mixture after twelve weeks.
Serum lipids Baseline (mmol/L) After treatment (mmol/L) Change % Probability
Triglycerides 2.06 ± 1.20 1.44 ± 0.92 −30 P ≤ 0.01
Total cholesterol 5.47 ± 1.35 5.01 ± 0.81 −7 P ≤ 0.05
HDL cholesterol 1.30 ± 0.11 1.27 ± 0.14 −2 ns
LDL cholesterol 3.24 ± 1.08 3.08 ± 0.40 −5 ns
TC/HDL ratio 4.26 ± 1.27 4.01 ± 0.75 −6 ns
LDL/HDL ratio 2.53 ± 0.98 2.47 ± 0.47 −2 ns
Tg/HDL ratio 1.61 ± 0.98 1.17 ± 0.76 −27 P ≤ 0.01
Total phospholipids 2.87 ± 0.74 2.50 ± 0.51 −13 ns
The values are means ± SD.
Table 3: Serum phospholipids fatty acid composition at baseline
and changes induced by dietary intervention.
Serum fatty acids Baseline After treatment
16:0 25.32 ± 2.39 23.87 ± 2.09∗∗
18:0 16.44 ± 1.74 15.05 ± 1.02∗∗
SFA 41.76 ± 3.22 38.93 ± 2.34∗∗∗
16:1n-7 0.39 ± 0.16 0.36 ± 0.15
18:1n-9 13.83 ± 1.68 14.92 ± 0.86∗
MUFA 14.59 ± 1.66 15.28 ± 0.94∗∗
18:2n-6 LA 24.49 ± 2.62 25.73 ± 1.85∗∗
20:3n-6 2.57 ± 0.79 2.96 ± 0.70∗∗
20:4n-6 11.63 ± 2.31 12.77 ± 2.56∗
22:4n-6 0.56 ± 0.14 0.61 ± 0.11
n-6 39.25 ± 3.25 42.06 ± 2.72∗∗∗
18:3n-3 LNA 0.08 ± 0.03 0.12 ± 0.02∗
20:5n-3 EPA 0.18 ± 0.05 0.22 ± 0.08∗
22:5n-3 0.46 ± 0.07 0.51 ± 0.10∗
22:6n-3 DHA 2.75 ± 0.33 2.99 ± 0.39∗∗
n-3 3.46 ± 0.37 3.84 ± 0.42∗∗∗
PUFA 42.71 ± 3.39 45.90 ± 2.69∗∗∗
n-6/n-3 ratio 11.34 ± 1.25 10.91 ± 1.59
PUFA/SFA ratio 1.03 ± 0.15 1.10 ± 0.14∗∗∗
The values are means ± SD. ∗P ≤ 0.05, ∗∗P ≤ 0.01, and ∗∗∗P ≤ 0.001
significantly different from baseline.
As mentioned above, dietary LA and ALA serve as the
precursors for the n-6 and n-3 series of PUFA, respectively,
and play an important role in modulation of cardiovascular,
inflammatory diseases, immune system, and blood pressure
regulation [4, 24, 43]. Their products modulate biosyn-
thesis of potent cellular mediators, eicosanoids. Therefore,
increased consumption of foodwith high n-6/n-3 PUFA ratio
leads to thrombosis and inflammatory reactions, while high
n-3/n-6 ratio has cardioprotective, antithrombotic, and anti-
inflammatory action [4, 44]. However, no reports are avail-
able on the effects of plant flax/pumpkin/sesame seedmixture
(rich in n-6 and n-3 FA), used as dietary supplement on
cardiometabolic risk factors in patients with renal disease
compared tomany studies withmarine n-3 fatty acid. Adding
seed mixture to the diets of hemodialysis patients resulted
in large drops in blood pressure (BP) of around 11mmHg
systolic and 6mmHgdiastolic after 12weaks.The evidence for
a hypotensive effect of flax or its components is unconvincing
[45, 46]. However, dietary supplementationwith 8 g/dayALA
for 12 weeks used by Paschos et al. [47] lowers both systolic
and diastolic BP in dyslipidemic men with magnitude of the
hypotensive effect (5mmHg or 3–6%). Study conducted by
Gossell-Williams et al. [48] showed that, in women, receiving
pumpkin seed oil (2 g/day) decreased diastolic BP.The antihy-
pertensive effect of seedmixture (rich in n-6 and n-3 FA)may
be caused by changes in prostaglandin synthesis, by alteration
of membrane fatty acid composition and by subsequent
changes in membrane functions [46]. Some investigators
have shown that flaxseed supplementation (30 g/day) lowers
serum creatinine in healthy subject (32 g/day) [45] and has
renoprotective effects in patients with lupus nephritis [49]. In
the present study, adding milled sesame/pumpkin/flax seeds
mixture (30 g; rich in n-6 and n-3 FA) in the habitual diet is
accompanied with reduction of serum creatinine levels. It is
well known that there was a strong association of severe pru-
ritus with depression symptoms, poorer sleep, and dry skin
in hemodialysis patients [27]. The decrease in frequency
symptoms of pruritus in our patients indicated that balanced
dietary n-6 and n-3 fatty acid intake improves symptoms of
pruritus.
This is the first exploration of the influence of added
milled sesame/pumpkin/flax seeds mixture in diet on serum
lipids and fatty acid status, so we have a coupled effect of
these plant food components. Flaxseed oil (2.4–3.6 g/day) has
not shown any hypolipidemic effect in supplementation trials
[50]. However, considering the publications, ground flaxseed
(30–50 g/day) [16, 17, 51] and sesame seed (50 g/day) [19]
have been shown to reduce blood lipids levels. In this regard,
meta-analyses on eleven studies examining the effect of whole
flaxseed supplementation on lipids levels reported that inter-
ventions reduced total and LDL cholesterol by 0.21mmol/L
and 0.16mmol/L, respectively [52]. It is noteworthy, that the
high content of dietary fiber and LA in the sesame seed
underlies its capacity to lower serum cholesterol levels [18].
In animalmodels of diabetes, pumpkin seeds supplemen-
tation decreased serum glucose, triglyceride and cholesterol,
and CRP levels [53]. It is assumed that the possible potential
mechanism of lipid lowering by pumpkin is probably due
to fibers effects. It is well known that dietary fiber reduces
plasma LDL cholesterol levels, by inhibiting the absorption
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Table 4: Correlation matrix between inflammatory markers and serum phospholipids fatty acid percentage in dietary intervention
treatments.
CRP IL-6 TNF ALA EPA DPA DHA n-3 LA DGLA AA n-6
CRP — 0.455∗∗ 0.392∗∗ −0.369∗∗ −0.112 −0.224 −0.282∗ −0.343∗∗ −0.123 −0.523∗∗ −0.255∗∗∗ −0.379∗∗
IL-6 — 0.780∗∗∗ −0.269∗ −0.185 −0.286∗ −0.213 −0.308∗ −0.232 −0.262∗ −0.293∗ −0.438∗∗
TNF — −0.587∗∗∗ −0.140 −0.197 −0.376∗∗ −0.403∗∗ −0.605∗∗∗ −0.319∗∗ −0.203 −0.370∗∗
∗
𝑃 < 0.05, ∗∗𝑃 < 0.01 and ∗∗∗𝑃 < 0.001.
of bile acids and cholesterol, and increases the activity of
LDL receptors. Recently, Makni et al. [54] have reported that
flax and pumpkin seed mixture supplemented in the diet of
diabetic rats has hypoglycemic, hypolipidemic, and nephro-
protector effect. In the present study we noticed significant
reduction in cholesterol by 8% in hemodialyses patients, after
dietary treatment with milled sesame/pumpkin/flax seed
mixture. LDL cholesterol is the primary target in cholesterol
lowering efforts in patients. In general, 1% increase in the LDL
cholesterol level may lead to 2-3% increase in coronary artery
disease risk [55]. Results of our study showed that added
milled sesame/pumpkin/flax seed mixture in diet decreases
slightly but not significantly serum LDL cholesterol by 5%.
Meta-analysis [56] based on population prospective stud-
ies showed that 1mmol/L increase in serum triglyceride
was associated with a 32% increase in a risk factor for
cardiovascular disease (CVD). In the present study, we
have 30% (0.6mmol/L) decreases in serum triglyceride
level in hemodialysis patients after dietary treatment with
milled sesame/pumpkin/flax seedmixture. However, the data
related to the protective role of ALA (3.0 g content of ALA in
our flax seed mixture) are less definitive than those of long
chain n-3, EPA, and DHA [57, 58]. This reduction in fasting
serum triglyceride during our intervention was in contrast
with the conclusion that the plant-derived n-3 fatty acid
is not equivalent to marine-based fatty acid in terms of
lowering triglyceride levels [52]. Our study results indicate
that sesame/pumpkin/flax diet treatment in hemodialyzed
patients could be beneficial in prevention of CVD as triglyc-
eride level is an important factor that has been implicated in
the pathogenesis of cardiovascular complication.
It was suggested that plant-based n-3 fatty acids might
influence insulin secretion in vivo and improve glucose use
and efficiency [59]. Findings from limited studies suggest that
flax meal improves insulin sensitivity, likely because of its
soluble fiber content, which may delay postprandial glucose
absorption in the gut. However, the trial by McManus et al.
[60] revealed no effect of n-3 fatty acids from flaxseed
oil on HbA1c, fasting glucose, or insulin levels in patients
with well-controlled type 2 diabetes. Dietary milled sesame/
pumpkin/flax seed mixture intakes in our study affect
glycemic control, significant decreased glucose levels, insulin,
and calculated IR HOMA in hemodialysis patients.
CRP plays an important role in atherogenesis [61].
Increased CRP levels exhibit synergy with concurrent hyper-
cholesterolemia to increase CVD risk in both men and
women [61]. Several studies have shown that CRP is inversely
associated with EPA and DHA levels in both healthy subjects
and in patients with stable coronary artery disease [62, 63].
Our results demonstrate that a dietary treatment with milled
sesame/pumpkin/flax seeds decreased CRP, IL-6, TNF-alpha
levels, and the changes in serum ALA and DHA levels, and
ALA+ DPA + EPA + DHA (total n-3 FA) were inversely
associated with changes in CRP and TNF-alpha. Therefore,
decreasing CRP levels, by dietary interventions, can improve
the lipid responses, thereby reducing overall CVD risk. In
diseases in which inflammation leads to adverse effects on the
progression of clinical parameters, such as renal failure, it is
necessary fact that dietary intervention that suppresses the
production of proinflammatory markers should be included
as part of the prevention. Nonetheless, in a recent systematic
review, a possible benefit of dietary ALA consumption in
reducing sudden death and nonfatal myocardial infarction
was deduced [44]. In line with this and because it has been
shown that the levels of serum fatty acids vary according to
the choice of different foods in the diet, dietary milled
sesame/pumpkin/flax seed mixture supplemented to the
habitual diet has beneficial effects on reducing CVD risk in
hemodialysis patients. For the interpretation of the results,
there should bementioned that therewas no placebo group as
a control and that dietary fatty acid intake was not assessed
by commonly used dietary assessment methods. Instead,
compliance was measured as a change in the serum phos-
pholipid fatty acid composition. Yet, despite these limitations,
the status biomarker of dietary fatty acid intake showed the
good patients’ compliance, whichmeans that the participants
adhered to the dietary intervention treatment. In conclusion,
milled 6 g sesame/6 g pumpkin/18 g flax seeds mixture per
day have possible health-promoting effects due to increased
levels of n-3 fatty acids in the serum and decreased inflamma-
tory markers. Further well-designed and controlled studies
are needed to determine if using seeds mixture might lead to
prevention or regression of atherosclerosis and the resolution
of some clinical problems in hemodialyzed patients.
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